April 11, 2018
As we proceed through the year, The Fedeli Group is committed to keeping you informed on industry trends and carrier performance. CVS Health, a major player in the pharmacy benefit management (PBM) industry recently released their annual Drug Trend Report. Among the highlights presented were the following:
• Reduced drug trend for commercial clients to 1.9%.
• Contained drug price growth to 0.2%.
• Lowered monthly drug cost per member by 10 cents to $11.89.
• Increased member adherence on key categories like diabetes, hypertension and hyperlipidemia by as much as 1.8%.
• Plans to address expensive Specialty drugs through targeted programs.
• Committed to help keep drugs affordable through their Saving Patients Money initiative that provides greater pricing transparency.
Click here to see the full Drug Trend Report
Our mission is to help clients protect assets and enhance employee outcomes through the delivery of exceptional risk management and employee benefit consulting services and products.
Receive our most recent blog articles, insights & news delivered straight to your inbox.
